- Home
- GCO vs DCTH Comparison
GCO vs DCTH Comparison
Compare GCO & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCO
- DCTH
- Stock Information
- Founded
- GCO 1924
- DCTH 1988
- Country
- GCO United States
- DCTH United States
- Employees
- GCO N/A
- DCTH N/A
- Industry
- GCO Clothing/Shoe/Accessory Stores
- DCTH Medical/Dental Instruments
- Sector
- GCO Consumer Discretionary
- DCTH Health Care
- Exchange
- GCO Nasdaq
- DCTH Nasdaq
- Market Cap
- GCO 314.3M
- DCTH 305.2M
- IPO Year
- GCO N/A
- DCTH N/A
- Fundamental
- Price
- GCO $29.60
- DCTH $9.39
- Analyst Decision
- GCO Hold
- DCTH Strong Buy
- Analyst Count
- GCO 2
- DCTH 4
- Target Price
- GCO $31.00
- DCTH $21.50
- AVG Volume (30 Days)
- GCO 132.3K
- DCTH 445.4K
- Earning Date
- GCO 11-29-2024
- DCTH 11-08-2024
- Dividend Yield
- GCO N/A
- DCTH N/A
- EPS Growth
- GCO N/A
- DCTH N/A
- EPS
- GCO N/A
- DCTH N/A
- Revenue
- GCO $2,301,050,000.00
- DCTH $22,644,000.00
- Revenue This Year
- GCO N/A
- DCTH $1,562.76
- Revenue Next Year
- GCO $1.43
- DCTH $117.72
- P/E Ratio
- GCO N/A
- DCTH N/A
- Revenue Growth
- GCO N/A
- DCTH 945.91
- 52 Week Low
- GCO $23.21
- DCTH $2.38
- 52 Week High
- GCO $37.89
- DCTH $12.88
- Technical
- Relative Strength Index (RSI)
- GCO 55.32
- DCTH 40.91
- Support Level
- GCO $28.70
- DCTH $10.11
- Resistance Level
- GCO $31.75
- DCTH $12.88
- Average True Range (ATR)
- GCO 1.27
- DCTH 0.66
- MACD
- GCO 0.32
- DCTH -0.23
- Stochastic Oscillator
- GCO 68.80
- DCTH 12.75
About GCO Genesco Inc.
Genesco Inc sells footwear, headwear, sports apparel, and accessories. The company has four reportable segments namely Journeys Group, derives maximum revenue which comprised of Journeys, Journeys Kidz, and Little Burgundy retail footwear chains, e-commerce operations, and catalog. Its Schuh Group is comprised of the Schuh retail footwear chain and e-commerce operations. The Johnston & Murphy Group is comprised of Johnston & Murphy retail operations, e-commerce operations, and catalog and wholesale distribution of products under the Johnston & Murphy and Genesco Brands Group. Licensed Brands, comprised of Dockers Footwear, under a license from Levi Strauss & Company.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.